First Patient Enrolled in Investigational Study of the GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System
Investigating the safety and effectiveness of a stent graft system designed to provide endovascular aneurysm repair (EVAR) with angulation control to patients previously considered untreatable
Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium<sup>®</sup>
Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts
W. L. GORE & ASSOCIATES CELEBRATES THE 50TH ANNIVERSARY OF ePTFE DISCOVERY
Expanded Polytetrafluoroethylene (ePTFE) Serves as a Core Material for Many Gore Innovations
Gore Unveils Next Evolution for TIPS Procedures: Lasting Diameter Control
GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion builds on a legacy of proven patency
Gore Receives Health Canada Approval for GORE® VIABAHN® Endoprosthesis Innovations, Treating Peripheral Vascular Disease
Longer and Lower Profile Options Now Available in Canada to Treat More Patient Anatomies
W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE
At the American Heart Association Virtual Scientific Sessions 2020.
W. L. Gore & Associates enhances GORE® VIABAHN® Endoprosthesis portfolio with lower profile delivery
Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization by adding radiopaque markers